Nicole Wistuba

The BioSciences Ventures Group AG operates as an association of business angels. Through its network, the association is able to invests in start-up life sciences companies within Germany, Austria and Switzerland. The association is headquartered in Munich, Germany.

Adriacell is a biotechnology company focused on the research and development of new generation biopharmaceuticals for the diagnosis and treatment of cancer. Its International team of highly qualified scientists is currently developing two: CROMOC, a tumor therapeutic agent and CERVIMAX which addresses the critical need for the early and accurate diagnosis of cervical cancer. Adriacell is a located in the Area Science Park of Trieste, Italy.

APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria.

MagnaMedics GmbH develops and markets biological diagnostic products. It specializes in the discovery and production of magnetic nano- and microparticles that are used in diagnostic kits for identifying biomarkers in body fluids. Its application areas encompass in-vitro diagnostics, genomics, protein and peptide, and research and development projects. It engages in partnerships with research and development laboratories and in-vitro diagnostics manufacturers. The company was founded by P. Mario Wuttke in 2003 and is headquartered in Aachen, Germany.

ugichem GmbH develops and manufactures antisense drugs. Its Ugimer platform intends to develop a pipeline of antisense drugs addressing unmet medical needs in indications involving inflammatory processes with focus on rheumatoid arthritis. The company was founded in 2003 by Ivar Ugi, Holger Bock, Thomas Lindhorst and is headquartered in Innsbruck, Austria.